Metabolic Risk Factors and Clinical Presentations of Metabolic Dysfunction-associated Steatotic Liver Disease Using Data from the All of Us Research Program

Key Points

• MASLD affects approximately 32% of the adult population, raising concerns about widespread metabolic dysfunction.
• Key findings indicate variations in clinical presentations of MASLD based on ethnicity and age among participants.
• Analysis utilizes data from the All of Us electronic health record-linked large cohort for comprehensive assessment.
• Highlights the need for targeted interventions that consider demographic differences in metabolic health.